Cohort Multiple Randomized Controlled Trial in Pediatric Asthma
ConditionPediatric Asthma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-18
SponsorMattienne van der Kamp
About this trial
The overarching goal of this study is to optimize pediatric asthma care and to continuously evaluate variations/innovations of the care (including transformation to remote eHealth care).
Primary Objectives within cmRCT cohort:
* Provide a framework for multiple randomized (eHealth) interventions for asthmatic children * Generate short- and long-term data on Quality of life (QoL), asthma outcomes (asthma control, lung function), quality of care, self-management capacity, healthcare use, and therapy compliance in a representative secondary care pediatric asthma cohort.
Secondary Objectives within cmRCT cohort:
* Evaluate current pediatric asthma care at the Pediatric department of Medisch Spectrum Twente, in order to explore possible improvements for the pediatric asthma care. * Compare the short and long-term asthma outcomes between the eHealth care path and the outpatient care path. * Compose patient risk profiles that include both personal, clinical and exposome markers and clinical asthma endpoints (for example clinical admission/exacerbations).
Eligibility criteria
Qualifiers
Is 4 to 18 years old
Is patient at the children's department at Medisch Spectrum Twente at moment of inclusion
Based on (typical) symptoms: (nighttime) wheezing, dyspnea, coughing (triggered by either viral infections, exercise, allergens or weather changes)
(Possibly) supplemented with a family history/atopy
Disqualifiers
The child and/or parent(s) has/have insufficient command of the Dutch language resulting in the insufficient ability to understand and/or answer questions
Trial design
Treatments tested in this trial
- video directly observed therapy (vDOT)
Treatment groups
300 Participants
are divided into 2 treatment groupsSponsors and collaborators
Mattienne van der Kamp
Lead sponsor
Medisch Spectrum Twente
Sponsor institution
Source ClinicalTrials.gov